(Q40325943)

English

Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases

scientific article published on 24 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Pharmacodynamics of β-lactamase inhibition by NXL104 in combination with ceftaroline: examining organisms with multiple types of β-lactamases (English)

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

pharmacodynamics

1 reference

based on heuristic

inferred from title

Mariana Castanheira

2

object named as

Mariana Castanheira

2 references

Europe PubMed Central

PMC publication ID

19 September 2017

ORCID Public Data File 2021

5

object named as

Ronald N Jones

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Robert W Kulawy

11

object named as

Robert Kulawy

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

1

object named as

Arnold Louie

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

author name string

Weiguo Liu

3

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Caroline Grasso

4

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Gregory Williams

6

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Ian Critchley

7

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Dirk Thye

8

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

David Brown

9

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Brian Vanscoy

10

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

G L Drusano

12

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

language of work or name

0 references

publication date

24 October 2011

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

56

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

1

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

258-270

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

Plasmid-mediated quinolone resistance: a multifaceted threat

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Pharmacodynamics of abacavir in an in vitro hollow-fiber model system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Hollow-fiber unit evaluation of a new human immunodeficiency virus type 1 protease inhibitor, BMS-232632, for determination of the linked pharmacodynamic variable

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

22 September 2017

Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

20 August 2018

Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3256033

20 August 2018

Identifiers

10.1128/AAC.05005-11

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40325943&oldid=2144156373"